Role of penicillin-binding protein 4 in expression of vancomycin resistance among clinical isolates of oxacillin-resistant Staphylococcus aureus.
about
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsMolecular Basis for the Role of Staphylococcus aureus Penicillin Binding Protein 4 in Antimicrobial ResistanceCeftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model.DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus.Exploring glycopeptide-resistance in Staphylococcus aureus: a combined proteomics and transcriptomics approach for the identification of resistance-related markers.Pseudomonas aeruginosa Alters Staphylococcus aureus Sensitivity to Vancomycin in a Biofilm Model of Cystic Fibrosis Infection.tcaA inactivation increases glycopeptide resistance in Staphylococcus aureus.Vancomycin susceptibility of oxacillin-resistant Staphylococcus aureus isolates causing nosocomial bloodstream infections.The msaABCR operon regulates resistance in vancomycin-intermediate Staphylococcus aureus strains.Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin.Transcriptomic and functional analysis of an autolysis-deficient, teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.Characterization of a novel small molecule that potentiates β-lactam activity against gram-positive and gram-negative pathogens.Intermediate vancomycin susceptibility in a community-associated MRSA clone.Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu3Mutation of RNA polymerase beta subunit (rpoB) promotes hVISA-to-VISA phenotypic conversion of strain Mu3.Staphylococcus aureus PBP4 is essential for beta-lactam resistance in community-acquired methicillin-resistant strains.The beta-lactam-resistance modifier (-)-epicatechin gallate alters the architecture of the cell wall of Staphylococcus aureus.Transcriptional induction of the penicillin-binding protein 2 gene in Staphylococcus aureus by cell wall-active antibiotics oxacillin and vancomycin.Microarray transcription analysis of clinical Staphylococcus aureus isolates resistant to vancomycinAlterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus.Phenotypic and genomic comparisons of highly vancomycin-resistant Staphylococcus aureus strains developed from multiple clinical MRSA strains by in vitro mutagenesis.Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics.Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid II.A mecA-negative strain of methicillin-resistant Staphylococcus aureus with high-level β-lactam resistance contains mutations in three genes.walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus.Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenemNovel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus.Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.Biosynthetic pathway for mannopeptimycins, lipoglycopeptide antibiotics active against drug-resistant gram-positive pathogensStrain-specific expression levels of pbp4 exist in isolates of glycopeptide-intermediate Staphylococcus aureus (GISA) and heterogeneous GISA.A Retrospective Analysis of Treatment and Clinical Outcomes among Patients with Methicillin-Susceptible Staphylococcus aureus Bloodstream Isolates Possessing Detectable mecA by a Commercial PCR Assay Compared to Patients with Methicillin-Resistant S
P2860
Q24646677-54E4F7E4-CE28-4964-B5DE-E261A49EA3BDQ27657968-8C3C23B8-515E-4348-A579-B02BFDC5C45FQ30452801-ECB716EA-D50C-49D9-BE7E-00EFE70213DEQ33220466-499428DD-B22E-4D78-99D7-E867CD1588DBQ33264418-E2FA925E-2814-49D0-A537-46262B992DAAQ33916479-830FD0A1-5937-4558-8B23-0249004BFD16Q34141289-FC02BC9A-D504-4A08-AE38-4323FD8EB089Q34198417-98FC69D5-8495-4BA7-AE94-3C8B18F4345CQ34596835-FCC0549E-1F0B-4AEC-905E-47D44D1BDF00Q34823746-B3405279-2730-45E6-B6BE-08529070C0CDQ35023285-2495BA3C-4F94-4586-AACF-4F303B41D8C9Q35169071-BAD74561-3B5A-4FE6-A659-79D4AE07B91EQ37302793-F0576E4C-5655-4AB6-B8E5-A34DD8FB87A5Q37335734-B3A39797-502D-43BF-91BC-E60FBC784B20Q38282740-1E8A1C2E-F551-4AE3-A43F-8D603A7B76AEQ38288054-39B75D02-1A70-46B0-8828-0A67F117C42AQ39720845-68A3E350-2D53-4E64-8851-871FEDEF070AQ39731937-EC558357-EF8E-43D0-9407-0411F560DE6EQ39791389-F7840D78-4069-4E54-BE59-286C16EEEF42Q40345457-9BE2D092-0EC9-479C-9745-B2FCC90ECDDBQ40896611-8D8433AD-0232-428A-91DD-C80BACFBDC73Q42001450-6BAFEAAE-E607-4592-919C-EFE2EBE64DAEQ42049579-8E2DD326-5612-428C-826B-E06C4B54E21CQ42109316-2D01EF2D-F110-45E7-B116-65417B9F05E3Q42110968-EDA4C8E0-1900-45AB-B769-CC1D53192B22Q42111612-9FC9D85D-22F1-4835-B4F0-1F19DE38569BQ42112516-D7C96D5C-00BE-4DE0-A62A-825E95A69EA4Q42119436-48E2082F-D03B-40AD-A0F7-8837836C6864Q42408769-4FB4B84C-FE75-4B58-B908-E5CC08B8A238Q42949210-0F31F441-6700-454D-9A52-863AA81F9D4DQ50077300-63781105-D407-4999-ADC6-ECD338F63D26
P2860
Role of penicillin-binding protein 4 in expression of vancomycin resistance among clinical isolates of oxacillin-resistant Staphylococcus aureus.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Role of penicillin-binding pro ...... sistant Staphylococcus aureus.
@en
Role of penicillin-binding pro ...... sistant Staphylococcus aureus.
@nl
type
label
Role of penicillin-binding pro ...... sistant Staphylococcus aureus.
@en
Role of penicillin-binding pro ...... sistant Staphylococcus aureus.
@nl
prefLabel
Role of penicillin-binding pro ...... sistant Staphylococcus aureus.
@en
Role of penicillin-binding pro ...... sistant Staphylococcus aureus.
@nl
P2093
P2860
P1476
Role of penicillin-binding pro ...... sistant Staphylococcus aureus.
@en
P2093
P2860
P304
P356
10.1128/AAC.45.11.3070-3075.2001
P407
P577
2001-11-01T00:00:00Z